Revenue GrowthSustained revenue growth indicates strong demand for the company's services, enhancing its market position and supporting long-term financial stability.

Operational EfficiencyImproved margins reflect effective cost management and operational prowess, which can lead to enhanced profitability and competitive advantage over time.

Balance Sheet HealthA robust balance sheet with prudent leverage ensures financial stability and flexibility, enabling the company to invest in growth opportunities and weather economic fluctuations.

Bears Say

Free Cash Flow VolatilityVolatile free cash flow due to high capital expenditures can strain financial resources, potentially limiting the company's ability to invest in strategic initiatives or respond to market changes.

Net Profit Margin FluctuationInconsistent net profit margins can indicate underlying cost pressures or inefficiencies, which may affect long-term profitability and shareholder returns.

Capital Expenditure ImpactHigh capital expenditures without corresponding cash flow improvements can impede financial flexibility, necessitating strategic adjustments to ensure sustainable growth.

9776 FAQ

What was Sapporo Clinical Laboratory Center, Inc.’s price range in the past 12 months?

Sapporo Clinical Laboratory Center, Inc. lowest stock price was ¥888.00 and its highest was ¥2074.00 in the past 12 months.

What is Sapporo Clinical Laboratory Center, Inc.’s market cap?

Sapporo Clinical Laboratory Center, Inc.’s market cap is ¥6.65B.

When is Sapporo Clinical Laboratory Center, Inc.’s upcoming earnings report date?

Sapporo Clinical Laboratory Center, Inc.’s upcoming earnings report date is May 18, 2026 which is in 88 days.

How were Sapporo Clinical Laboratory Center, Inc.’s earnings last quarter?

Sapporo Clinical Laboratory Center, Inc. released its earnings results on Feb 06, 2026. The company reported ¥12.54 earnings per share for the quarter, beating the consensus estimate of N/A by ¥12.54.

Is Sapporo Clinical Laboratory Center, Inc. overvalued?

According to Wall Street analysts Sapporo Clinical Laboratory Center, Inc.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Sapporo Clinical Laboratory Center, Inc. pay dividends?

Sapporo Clinical Laboratory Center, Inc. pays a Annually dividend of ¥23 which represents an annual dividend yield of 1.17%. See more information on Sapporo Clinical Laboratory Center, Inc. dividends here

What is Sapporo Clinical Laboratory Center, Inc.’s EPS estimate?

Sapporo Clinical Laboratory Center, Inc.’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Sapporo Clinical Laboratory Center, Inc. have?

Sapporo Clinical Laboratory Center, Inc. has 4,216,000 shares outstanding.

What happened to Sapporo Clinical Laboratory Center, Inc.’s price movement after its last earnings report?

Sapporo Clinical Laboratory Center, Inc. reported an EPS of ¥12.54 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went same 0%.

Which hedge fund is a major shareholder of Sapporo Clinical Laboratory Center, Inc.?

Currently, no hedge funds are holding shares in JP:9776

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Sapporo Clinical Laboratory Center, Inc.

Sapporo Clinical Laboratory Inc. operates dispensing pharmacies in Japan. The company offers clinical examination, pathological examination, and holter examination services. It provides food hygiene environmental inspection, including food/processed product, facility hygiene, and food handler inspection services; and radiation management services. In addition, the company develops, sells, and maintains software, such as SCAN clinical testing systems; and offers support services for opening new clinics. Further, it provides HiWeb21 inspection result inquiry services, as well as sells and maintains software relating to clinical testing. The company was incorporated in 1965 and is based in Sapporo, Japan.